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Pityriasis Lichenoid-like Mycosis Fungoides in a  
9-year-old Boy: A Case Report 
Dear Editors,
Pityriasis lichenoides (PL)-like mycosis fungoides 
(MF) is a rare variant of MF, presenting clinical find-
ings of PL but histological features of MF. It was first 
reported by Ko et al. (1) and only a few cases have 
been reported since (2-5). Herein we report the case 
of a boy with PL-like MF and review the related litera-
ture.
A 9-year-old boy presented with a 1-year history of 
multiple pruritic crusted erythematous papules and 
scaly pink maculopatches on the face, trunk, and ex-
tremities (Figure 1, a and b). Histologic examination of 
a papule revealed lymphocytic epidermotropism and 
lymphocytes tagging the dermoepidermal junction. 
The nuclei of the lymphocytes were hyperchromatic 
and irregular (Figure 1, c and d). Immunohistochemi-
cally, the infiltrating lymphocytes revealed positivity 
for CD2, CD3, CD5, CD7, and CD8, but were nega-
tive for CD4, CD20, CD30, CD68, and CD163 (Figure 
1, e-g). T-cell receptor gene rearrangement analysis 
(TCR-GRA) demonstrated the rearrangement of the 
Figure 1. (a) Generalized crusted erythematous papules and white to pink scaly maculopatches on the trunk and upper limbs. 
(b) Close-up view of the brownish to erythematous crusted scaly papules and hypopigmented maculopatches on the chest. 
(c) Epidermotropism of atypical lymphocytes with perinuclear halo and lymphocytes tagging the dermoepidermal junction 
(hematoxylin and eosin (HE), ×200). (d) Atypical lymphocytes with hyperchromatic irregular, convoluted, or cerebriform nuclei 
(HE, × 400). Immunohistochemical stain (original magnification ×200): (e) positive for CD3, (f ) negative for CD4, and (g) posi-
tive for CD8. (h) T-cell receptor gene rearrangement analysis demonstrating rearrangement of the gamma chain.
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IHC stain TCR-GRA Treatment & response
11/M/10 T/E M/Pa/S 12 CD3 (+), CD20 (-), CD30 (-) γ chain PUVA; CR 
21/M/5 T/E M/Pa/PA/S 12 CD3 (+), CD20 (-), CD30 (-) γ chain PUVA; Response NA
31/M/4 T/E Pa/S 24 CD3 (+), CD20 (-), CD30 (-) γ chain Loss follow-up
42/F/60 T Pa/S 6 CD3 (+), CD4 (+), CD8 (-), CD20 (-) γ chain Topical steroid; CR 
53/F/32 T/E M/Pa/S 120 CD3 (+), CD4 (-), CD8 (+) γ chain NA
64/M/52 T/E Pa 60 CD3 (+), CD4 (+), CD8 (-), CD20 (-), CD30 (-) Polyclonal Multi-therapyb; Persistence
74/F/70 T/E Pa 60 CD3 (+), CD4 (+), CD8 (-), CD20 (-), CD30 (-) Polyclonal Multi-therapyc; Persistence
84/F/49 T/E Pa 24 CD3 (+), CD4 (+), CD8 (-), CD20 (-), CD30 (-) Polyclonal Multi-therapyd; Persistence
94/M/35 T/pubic Pa 12 CD3 (+), CD4 (+), CD8 (-), CD20 (-), CD30 (-) Monoclonal PUVA; CR
105/M/4 T/E Pa/S 12 CD3 (+), CD4<CD8, CD30 (-) Monoclonal PUVA; CR
115/M/7 T/E M/Pa 6 CD3 (+), CD4<CD8, CD30 (-) Monoclonal PUVA; CR  
125/M/8 T/E M/Pa 24 CD3 (+), CD4<CD8, CD30 (-) Monoclonal PUVA; CR
135/M/7 T/E Pa/S 1 CD3 (+), CD4<CD8, CD30 (-) NA No treatment
145/M/10 T/E M/Pa 36 CD3 (+), CD4<CD8, CD30 (-) Polyclonal NBUVB; CR
155/M/19 G Pa/S 14 CD3 (+), CD4<CD8, CD30 (-) Monoclonal NBUVB; CR
165/M/44 T/E Pa/PA 1 CD3 (+), CD4>CD8, CD30 (-) Monoclonal NBUVB; CR
175M/10 T/E M/Pa 5 CD3 (+), CD4>CD8, CD30 (-) Monoclonal NBUVB; CR
185/M/59 T/E M/Pa 60 CD3 (+), CD4<CD8, CD30 (-) NA No treatment
195/M/5 G M/Pa 5 CD3 (+), CD4>CD8, CD30 (-) Monoclonal NBUVB; CR; Recurrence
205/F/25 T/E Pa/PA 2 CD3 (+), CD4<CD8, CD30 (-) Polyclonal NBUVB; CR
215/F/7 T/E M/Pa 1 CD3 (+), CD4<CD8, CD30 (-) Monoclonal NBUVB; CR
225/M/11 E Pa/Pl 20 CD4>CD8, CD30 (-) NA NBUVB; CR
235/M/18 T/E Pa 48 CD4<CD8 NA NBUVB; CR




G Pa/S 12 CD3 (+), CD4 (-), CD8 (+), CD20 (-), CD30 (-) γ chain NBUVB; CR
Summary
• Total of 25 cases; M/F 18/7; mean age 23.4 years of age (range 4-70 years)
•  Location: the whole body (3), trunk & extremities (19), trunk only (2), extremities only (1)
•  Symptoms (NA in 5 cases): pruritic/asymptomatic 12/8
•  Mean interval between presence of lesions and diagnosis: 23.5 months (range 1-120 months)
•  Histological findings: epidermotropism 100% (25/25), haloed lymphocytes 68% (17/25), tagging of lymphocytes along the  
   dermoepidermal junction 64% (16/25), coarse collagen bundles in the dermal papillae 56% (14/25), Pautrier’s microabscesses 36%  
   (9/25)
•  IHC stain for CD4 & CD8 (NA in 4 case): CD8>CD4 in 57% (12/21), CD4>CD8 in 43% (9/21)
•  TCR-GRA (NA in 5 cases): monoclonal 75% (15/20), polyclonal 25% (5/20)
•  Treatment: phototherapy in 20 cases, with CR 80% (16/20), poor response 15% (3/20), and response unavailable 5% (1/20)
T: trunk; E: extremities; G: generalized; M: macules; Pa: papules; PA: patch; Pl: plaque; S: scales; IHC stain: immunohistochemical stain; 
TCR-GRA: T-cell receptor gene rearrangement analysis; NA: not available; CR: complete remission; PUVA: psoralen combined with 
ultraviolet A; NBUVB: narrow band ultraviolet B
aInterval indicates the interval between presence of lesions and being diagnosed with mycosis fungoides
bTopical steroids, erythromycin, PUVA
cTopical steroids, total skin electron irradiation, PUVA, NBUVB, Bexarotene
dTopical steroids, PUVA, interferon
Table 1. Clinical and pathologic features of previously reported 24 pityriasis lichenoid-like mycosis fungoides patients and 
our patient Patient no./gender/age of diagnosis
gamma chain (Figure 1, h). PL-like MF was diagnosed. 
The patient was started on narrowband ultraviolet 
B (NBUVB) phototherapy. The skin lesions markedly 
improved after 6 months of treatment. There was no 
recurrence during the 2 years of follow-up.
There has long been a controversy regarding 
whether PL is just an inflammatory dermatosis or a 
genuine T-cell lymphoproliferative disease. Wang et 
al. (2) proposed three categories for the relationship 
between PL and MF: (A) PL with a dominant T-cell 
clone, (B) PL subsequently progressing into MF, and 
(C) PL-like MF. In the first category, PL is a monoclo-
nal T-cell-mediated inflammatory disorder, in which 
T-cell clones were found in about 50% of patients 
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(6,7). The second category involves progression from 
long-term PL to MF (8,9). The average time-to-pro-
gression is about 8 years. It has been speculated that 
the PL-related immunologic microenvironment is fa-
vorable for developing a tumoral clone. Our patient 
presented with PL-like lesions clinically, while biopsy 
findings, results of immunohistochemistry, and TCR-
GRA all suggested that this case was MF. Due to the 
short duration (only one year) of his lesions, we estab-
lished the diagnosis of PL-like MF de novo, rather than 
evolution from PL to MF.
The features of previously reported cases of PL-
like MF and those of our patient are summarized in 
Table 1 (1-5). Men were predominant (18:7) among 
the total of 25 patients. Most patients were children 
or young adults (mean age of 23.4 years).The inter-
val between presence of lesions and diagnosis varied 
from 1 month to 10 years. The cutaneous eruptions 
were all PL in appearance and almost all involved 
both the trunk and extremities. Pruritus was reported 
by approximately half of the patients. Histologically, 
the scaly papules were usually indistinguishable from 
classical MF, showing epidermotropism, haloed lym-
phocytes, lymphocytes aligning along the dermoepi-
dermal junction, and Pautrier’s microabscesses. Im-
munohistochemically, all tested cases demonstrated 
positivity for CD3 but were negative for CD20 and 
CD30. Cases with predominantly CD8-positive cells 
were twice as prevalent as cases with predominant-
ly CD4-positive cells. TCR-GRA was performed in 20 
cases, 15 of which revealed monoclonality. Most pa-
tients received psoralen combined with ultraviolet A 
or NBUVB phototherapy, and demonstrated either a 
complete or partial response. Recurrence was report-
ed in only 2 cases (5).
In summary, PL-like MF is a rare variant of MF. It 
has some features distinct from classic MF, such as a 
higher incidence in young men and predominantly 
CD8-positive T-cells infiltration. Phototherapy can be 
used as the first line of treatment. A good response 
and a favorable prognosis can be expected.
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